Search clinical trials for: NeuVax vaccine

Total 6453 results

LG Life Sciences

Completed

Immunogenicity and Safety Study of LBVH0101 in Healthy Infants at Two, Four and Six Months of Age

Infectious Disease by Haemophilus Influenzae Type b

Korea, Republic of
Sinovac Biotech Co., Ltd
Shaanxi Provincial Center for Disease Control and Prevention

Completed

Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With Expanded Programme on Immunization Vaccines

Hand, Foot and Mouth Disease

China
The University of Hong Kong

Recruiting

Intradermal COVID-19 Vaccination in the Immunocompromised

Immunocompromised Patients | Intradermal Covid-19 Vaccine | Immungenicity and Safety | Randomized Trial

Hong Kong
The Second Affiliated Hospital of Chongqing Medical...

Recruiting

Safety and Immune Response of COVID-19 Vaccination in Patients With HIV Infection

HIV Infections | Covid19

China
University of Bergen
Norwegian University of Science and Technology; International Centre for Diarrhoeal...

Active, not recruiting

An Effectiveness Trial to Evaluate Protection of Children and Pregnant Women by Influenza Vaccine in Rural Bangladesh (FluEffect)

Influenza Viral Infections

Bangladesh, Norway
Emergent BioSolutions
Walter Reed Army Institute of Research (WRAIR)

Terminated

A Study to Assess the Safety, Pharmacodynamics, and Immunogenicity of PXVX0047

Adenoviral Infection

United States
Xiamen University
Xiamen Innovax Biotech Co., Ltd; Beijing Wantai Biological Pharmacy Enterprise...

Active, not recruiting

Efficacy, Immunogenicity and Safty Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)

Cervical Cancer | Cervical Intraepithelial Neoplasia | Condylomata Acuminata

China
LEO Pharma

Completed

Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5) (ECZTRA 5)

Atopic Dermatitis

United States, Canada
Steinar Aamdal

Terminated

Trial of Vaccine Therapy in Recurrent Platinum Sensitive Ovarian Cancer Patients

Recurrent Epithelial Ovarian Cancer

Norway
University of Texas at Austin

Unknown

Influenza Vaccine as a Novel Experimental Model of the Behavioral Immune Response in Depression

Depression | Healthy

United States
GlaxoSmithKline

Completed

Study to Evaluate Immunological Equivalence Between Two Investigational Influenza Vaccines in Adults (H1N1)

Influenza

France, Germany
Tan Tock Seng Hospital
National Healthcare Group, Singapore

Completed

Tropical Influenza Control Strategies for the Elderly (TROPICS1)

Influenza, Human

Singapore
Virginia Commonwealth University
CMV Research Foundation Inc

Terminated

Evaluation of the Safety and Immune Responses of the Towne Strain of CMV in Seronegative Women

Cytomegalovirus Infections

United States
Novartis Vaccines

Completed

Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Children

Prevention of Meningococcal Disease

United States
International Centre for Diarrhoeal Disease Research...
Government of Bangladesh; International Vaccine Institute

Completed

To Determine the Safety and Immunogenicity of an Oral Whole Cell ShanChol Cholera Vaccine in Bangladesh

Healthy

Bangladesh
University Hospitals, Leicester
Novartis; Public Health England; Centers for Disease Control and Prevention

Completed

Heterosubtypic Immune Responses to Influenza in Older People

Influenza

United Kingdom
Sanofi Pasteur, a Sanofi Company

Completed

Safety, Tolerability, and Immune Response of ACAM3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine in Adults

Smallpox

United States
LG Life Sciences

Completed

Immunogenicity and Safety Study of 4th LBVH0101 After the Primary Vaccination in LG-VHCL002 Study

Infectious Disease by Haemophilus Influenzae Type b

Korea, Republic of
University of Sao Paulo General Hospital

Unknown

Serological Evaluation of Varicella and Hepatitis A Vaccines Using Injector Delivery (InjHepAVar)

Hepatitis A | Varicella

Brazil
University Hospital Inselspital, Berne
Merck Sharp & Dohme LLC; Boehringer Ingelheim; Abbott; Solvay Pharmaceuticals

Completed

Influenza Vaccination in Immunocompromized Patients

Immunosuppression

Switzerland
Sichuan Center for Disease Control and Prevention
China National Biotec Group Company Limited

Unknown

The Safety and Immunogenicity Study of Rotavirus Vaccine Simultaneously Vaccinated With MR or MMR Vaccine

Rotavirus
Dalhousie University

Unknown

A Controlled Study to Evaluate the Safety and Immunogenicity of StreptAnova™ in Healthy Adults

Healthy

Canada
Huntington Memorial Hospital

Completed

Post COVID-19 Vaccination Analysis in Healthcare Worker Recipients

Covid19 | Vaccine Reaction

United States
PT Bio Farma

Completed

Immunogenicity and Safety of Vi-DT (Diphtheria Toxoid) Typhoid Conjugate Vaccine (Phase III)

Safety Issues | Immunogenicity

Indonesia
LimmaTech Biologics AG

Completed

Phase I to Test a New Pneumococcal Vaccine

Pneumonia, Bacterial | Pneumococcal Pneumonia

Germany
University Health Network, Toronto

Completed

Adjuvanted Influenza Vaccine in Stem Cell Transplant

Transplantation | Influenza Vaccines
University of British Columbia
Canadian Institutes of Health Research (CIHR)

Completed

Evaluation of Meningococcal C Vaccine Programmes in Canadian Children

Meningococcal Sero-type C Infection

Canada
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Completed

Phase Ⅲ Clinical Study of Quadrivalent Influenza Virus Split Vaccine

Prevention of Influenza

China
Themis Bioscience GmbH
Walter Reed Army Institute of Research (WRAIR)

Completed

Study of a Live Attenuated Chikungunya Vaccine in a Previously Epidemic Area

Chikungunya

Puerto Rico
Insight Therapeutics, LLC
Brown University; Case Western Reserve University

Unknown

High-Dose Influenza Vaccine in Nursing Homes

Influenza

United States
National Institute on Aging (NIA)

Completed

PPV: Pneumococcal Polysaccharide Vaccine in Older Adults

Aging

United States
Haukeland University Hospital
Helse Vest

Terminated

Vaccines and Dietary Oats in the Treatment of Ulcerative Colitis

Ulcerative Colitis

Norway
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.; Guizhou Center for Disease... and other collaborators

Recruiting

Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine (Sinopharm BBIBP-CorV) Coadministered With Rabies Vaccine

COVID-19 | Rabies

China
Ain Shams University

Recruiting

Profiling Antibody Status and Vaccine Effectiveness in Post Vaccination With SARS CoV2 in Ain Shams University (ASU-VAC)

Covid19

Egypt
Mahidol University
The Government Pharmaceutical Organization (GPO) Bangkok, Thailand

Active, not recruiting

Safety and Immunogenicity of GPO Seasonal Tetravalent Inactivated Split Virion Influenza Vaccine in Healthy Thais

Influenza

Thailand
University of California, San Francisco

Active, not recruiting

The BOOSTED (Booster Options Or Switching Tested for Effectiveness and Downsides Study) Trial (COVID-19) (BOOSTED)

COVID-19 | Vaccine Reaction | COVID-19 Pandemic

United States
PT Bio Farma
Dr. Soetomo General Hospital

Completed

Safety and Tuberculin Conversion Following BCG Vaccination

BCG Vaccination Reaction

Indonesia
National Institute of Allergy and Infectious Diseases...

Completed

Early Immune Responses to Vaccination - A Substudy to HVTN 205

HIV Infections

United States
U.S. Army Medical Research and Development Command

Enrolling by invitation

Continued Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine

Tularemia

United States
Merck Sharp & Dohme LLC

Completed

Immunogenicity and Tolerability of V503 Versus GARDASIL (V503-009)

Human Papillomavirus
University of Missouri-Columbia

Withdrawn

Therapeutic Treatment With Human Papillomavirus Quadrivalent Vaccine for Recurrent Respiratory Papillomatosis

Recurrent Respiratory Papillomatosis

United States
Novartis
Novartis Vaccines

Completed

Safety, and Immunogenicity of Two Influenza Vaccines in Healthy Subjects 3 to 64 Years Old

Influenza

Argentina
Jiangsu Province Centers for Disease Control and...

Completed

Study of Adsorption Tetanus-diphtheria-acellular Pertussis (DTaP) Vaccine in Healthy 3 to 5 Months Infants

Pertussis

China
Statens Serum Institut

Completed

Immunogenicity and Safety of Tetanus, Diphtheria and Mono Component Acellular Pertussis (TdaP) Vaccine in Comparison to Tetanus and Diphtheria (Td) Vaccine When Given as Booster Vaccinations to Adults

Healthy

Denmark
University Hospitals, Leicester
Public Health England; Novartis Vaccines

Completed

Safety and Immunogenicity of A/H1N1v Vaccines in Healthy Adults

Influenza

United Kingdom
Shiraz University of Medical Sciences

Completed

The Immunogenicity of Intradermal Influenza Vaccination in Hemodialysis Patients

Hemodialysis Patients

Iran, Islamic Republic of
GlaxoSmithKline

Completed

Study to Evaluate Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals' Candidate Malaria Vaccine (257049)

Malaria | Malaria Vaccines

Ghana, Burkina Faso
Mayo Clinic
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Gene Signatures of Influenza Vaccine Responses in Older Adults

Influenza

United States
Oriol Manuel
University of Zurich; University Hospital, Geneva; University Hospital, Basel... and other collaborators

Completed

Reducing the Burden of Influenza After Solid-Organ Transplantation (STOP-FLU)

Influenza | Organ Transplantation

Switzerland, Spain
GlaxoSmithKline

Completed

Co-administration of Meningococcal Vaccine GSK134612 and Pneumococcal Vaccine GSK1024850A vs Individual Administration

Infections, Meningococcal

Taiwan, Mexico

Search clinical trials for: NeuVax vaccine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Togo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations